English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Serum adenylate kinase (AK) activity was measured in cerebral vascular diseases and the AK isoenzyme pattern was studied in the patients suffering from cerebral infarction, cerebral hemorrhage, myocardial infarction, and polymyositis. There was a significant difference in AK activity between the control subjects and patients with acute cerebral infarction. Serum AK activity showed a peak on the 2nd day to the 4th day after the stroke attack, maintained at high level for about one week, and decreased gradually thereafter. There were three isoenzymes (AK-1, AK-2, AK-3) of AK, and we found that the AK isoenzyme patterns were different in different disease. The AK isoenzyme patterns in patients with cerebral infarction and cerebral hemorrhage were different from those of control subjects. The AK-3 isoenzyme was dominant in the control subjects. The proportion of AK-1 isoenzyme was increased in cerebral infarction and cerebral hemorrhage compared with that for the control subjects, and the proportion of AK-2 isoenzyme was elevated in acute myocardial infarction and polymyositis. These results suggest that serum AK is a sensitive indicator of cerebral infarction and a useful marker to follow the course of patient recovery. Moreover, the analysis of AK isoenzymes is useful in the diagnosis of cerebral vascular diseases.

Serum adenylate kinase activity and isoenzyme in acute cerebral vascular disease.